{"entity":{"type":"insider","cik":"0001524314","url":"/insider/0001524314","json_url":"/insider/0001524314.json","name":"Cohen Chad M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":139,"n_filings":80,"first":"2011-07-27","last":"2021-12-23","span_basis":"filed_date"},"name_variants":[{"name":"Cohen Chad M","source":"filing","n_filings":80,"first_seen":"2011-07-27","last_seen":"2021-12-23"}],"transactions":[{"id":5209793,"accession":"0001209191-21-071193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-071193","line_url":"/filing/0001209191-21-071193#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-23","scope":"insider"},{"id":5348012,"accession":"0001209191-21-064253","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-064253","line_url":"/filing/0001209191-21-064253#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":33.93,"price_display":"33.93","price_state":"stated","total_value":169650.0,"total_display":"169,650.00","total_whole":"169,650","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider"},{"id":5348001,"accession":"0001209191-21-064253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-064253","line_url":"/filing/0001209191-21-064253#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":36.03,"price_display":"36.03","price_state":"stated","total_value":180150.0,"total_display":"180,150.00","total_whole":"180,150","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-12","scope":"insider"},{"id":4385674,"accession":"0001209191-21-059985","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-059985","line_url":"/filing/0001209191-21-059985#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.3,"price_display":"32.30","price_state":"stated","total_value":161500.0,"total_display":"161,500.00","total_whole":"161,500","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-06","filed_date":"2021-10-07","scope":"insider"},{"id":4385663,"accession":"0001209191-21-059985","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-059985","line_url":"/filing/0001209191-21-059985#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.51,"price_display":"32.51","price_state":"stated","total_value":162550.0,"total_display":"162,550.00","total_whole":"162,550","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-07","scope":"insider"},{"id":5202596,"accession":"0001209191-21-055368","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-055368","line_url":"/filing/0001209191-21-055368#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":39.01,"price_display":"39.01","price_state":"stated","total_value":195050.0,"total_display":"195,050.00","total_whole":"195,050","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-08","filed_date":"2021-09-09","scope":"insider"},{"id":5202589,"accession":"0001209191-21-055368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055368","line_url":"/filing/0001209191-21-055368#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9375.0,"shares_display":"9,375","price_per_share":39.71,"price_display":"39.71","price_state":"stated","total_value":372281.25,"total_display":"372,281.25","total_whole":"372,281","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider"},{"id":5381507,"accession":"0001209191-21-051275","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-051275","line_url":"/filing/0001209191-21-051275","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":33.604938,"price_display":"33.60","price_state":"stated","total_value":336049.38,"total_display":"336,049.38","total_whole":"336,049","shares_owned_after":22866.0,"shares_owned_after_display":"22,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-12","scope":"insider","n_lines":2},{"id":5381504,"accession":"0001209191-21-051275","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-051275","line_url":"/filing/0001209191-21-051275#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":175000.0,"total_display":"175,000.00","total_whole":"175,000","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-12","scope":"insider"},{"id":4181788,"accession":"0001209191-21-046082","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-046082","line_url":"/filing/0001209191-21-046082","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":38.531942,"price_display":"38.53","price_state":"stated","total_value":385319.42,"total_display":"385,319.42","total_whole":"385,319","shares_owned_after":25118.0,"shares_owned_after_display":"25,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-08","scope":"insider","n_lines":2},{"id":4181780,"accession":"0001209191-21-046082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-046082","line_url":"/filing/0001209191-21-046082#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":38.83,"price_display":"38.83","price_state":"stated","total_value":388300.0,"total_display":"388,300.00","total_whole":"388,300","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-08","scope":"insider"},{"id":5292636,"accession":"0001209191-21-039637","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-039637","line_url":"/filing/0001209191-21-039637#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.6,"price_display":"35.60","price_state":"stated","total_value":356000.0,"total_display":"356,000.00","total_whole":"356,000","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-10","scope":"insider"},{"id":5292628,"accession":"0001209191-21-039637","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-039637","line_url":"/filing/0001209191-21-039637","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":37.051905,"price_display":"37.05","price_state":"stated","total_value":370519.05,"total_display":"370,519.05","total_whole":"370,519","shares_owned_after":23203.0,"shares_owned_after_display":"23,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-10","scope":"insider","n_lines":2},{"id":5475854,"accession":"0001209191-21-032438","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-032438","line_url":"/filing/0001209191-21-032438#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.63,"price_display":"32.63","price_state":"stated","total_value":326300.0,"total_display":"326,300.00","total_whole":"326,300","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":5475845,"accession":"0001209191-21-032438","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-032438","line_url":"/filing/0001209191-21-032438","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":31.534193,"price_display":"31.53","price_state":"stated","total_value":315341.93,"total_display":"315,341.93","total_whole":"315,342","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider","n_lines":2},{"id":5490353,"accession":"0001209191-21-026183","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-026183","line_url":"/filing/0001209191-21-026183","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":41.65045,"price_display":"41.65","price_state":"stated","total_value":416504.5,"total_display":"416,504.50","total_whole":"416,505","shares_owned_after":22410.0,"shares_owned_after_display":"22,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-04-08","scope":"insider","n_lines":2},{"id":5490344,"accession":"0001209191-21-026183","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-026183","line_url":"/filing/0001209191-21-026183#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.95,"price_display":"40.95","price_state":"stated","total_value":409500.0,"total_display":"409,500.00","total_whole":"409,500","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-06","filed_date":"2021-04-08","scope":"insider"},{"id":5423768,"accession":"0001209191-21-020302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-020302","line_url":"/filing/0001209191-21-020302#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":42.54,"price_display":"42.54","price_state":"stated","total_value":425400.0,"total_display":"425,400.00","total_whole":"425,400","shares_owned_after":21604.0,"shares_owned_after_display":"21,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-12","scope":"insider"},{"id":5394981,"accession":"0001209191-21-019621","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-019621","line_url":"/filing/0001209191-21-019621","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.24253,"price_display":"40.24","price_state":"stated","total_value":402425.3,"total_display":"402,425.30","total_whole":"402,425","shares_owned_after":23954.0,"shares_owned_after_display":"23,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-09","filed_date":"2021-03-10","scope":"insider","n_lines":2},{"id":5144475,"accession":"0001209191-21-006576","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-006576","line_url":"/filing/0001209191-21-006576","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":56.0309152,"price_display":"56.03","price_state":"stated","total_value":2801545.76,"total_display":"2,801,545.76","total_whole":"2,801,546","shares_owned_after":12888.0,"shares_owned_after_display":"12,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-29","filed_date":"2021-02-01","scope":"insider","n_lines":3},{"id":5144466,"accession":"0001209191-21-006576","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-006576","line_url":"/filing/0001209191-21-006576","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":56.2211032,"price_display":"56.22","price_state":"stated","total_value":2811055.16,"total_display":"2,811,055.16","total_whole":"2,811,055","shares_owned_after":19523.0,"shares_owned_after_display":"19,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-28","filed_date":"2021-02-01","scope":"insider","n_lines":3},{"id":5034749,"accession":"0001209191-21-005751","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-21-005751","line_url":"/filing/0001209191-21-005751","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":64.0414826,"price_display":"64.04","price_state":"stated","total_value":3202074.13,"total_display":"3,202,074.13","total_whole":"3,202,074","shares_owned_after":6920.0,"shares_owned_after_display":"6,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider","n_lines":4},{"id":5034730,"accession":"0001209191-21-005751","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-005751","line_url":"/filing/0001209191-21-005751","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":66.0676306,"price_display":"66.07","price_state":"stated","total_value":3303381.53,"total_display":"3,303,381.53","total_whole":"3,303,382","shares_owned_after":19436.0,"shares_owned_after_display":"19,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider","n_lines":4},{"id":4981842,"accession":"0001209191-21-004973","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-004973","line_url":"/filing/0001209191-21-004973","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":67.3311052,"price_display":"67.33","price_state":"stated","total_value":3366555.26,"total_display":"3,366,555.26","total_whole":"3,366,555","shares_owned_after":6012.0,"shares_owned_after_display":"6,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-22","scope":"insider","n_lines":3},{"id":4981815,"accession":"0001209191-21-004772","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-004772","line_url":"/filing/0001209191-21-004772","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":68.6084242,"price_display":"68.61","price_state":"stated","total_value":3430421.21,"total_display":"3,430,421.21","total_whole":"3,430,421","shares_owned_after":33366.0,"shares_owned_after_display":"33,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider","n_lines":5},{"id":5243096,"accession":"0001209191-21-003835","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-003835","line_url":"/filing/0001209191-21-003835","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":63.405356,"price_display":"63.41","price_state":"stated","total_value":3170267.8,"total_display":"3,170,267.80","total_whole":"3,170,268","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-13","filed_date":"2021-01-15","scope":"insider","n_lines":2},{"id":4611632,"accession":"0001209191-21-003492","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-003492","line_url":"/filing/0001209191-21-003492#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001524314","owner_name":"Cohen Chad M","owner_display_name":"Cohen Chad M","owner_url":"/insider/0001524314","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39973.0,"shares_display":"39,973","price_per_share":62.25,"price_display":"62.25","price_state":"stated","total_value":2488319.25,"total_display":"2,488,319.25","total_whole":"2,488,319","shares_owned_after":36027.0,"shares_owned_after_display":"36,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-13","scope":"insider"}],"collapsed":true,"next_cursor":"2021-01-12|4611632","ledger_fault":false,"count":{"value":139,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":137,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":139},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Officer (Chief Financial Officer)","n_filings":36,"first_seen":"2019-07-03","last_seen":"2021-12-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001371285","name":"TRUPANION, INC.","url":"/issuer/0001371285","role":"Director","n_filings":1,"first_seen":"2018-11-28","last_seen":"2018-11-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001617640","name":"ZILLOW GROUP, INC.","url":"/issuer/0001617640","role":"Officer (CFO & Treasurer)","n_filings":1,"first_seen":"2015-02-19","last_seen":"2015-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001334814","name":"ZILLOW INC","url":"/issuer/0001334814","role":"Officer (CFO & Treasurer)","n_filings":42,"first_seen":"2011-07-27","last_seen":"2015-01-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001524314","retrieved_at":"2026-08-25T03:42:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}